What's Happening?
The Centers for Medicare & Medicaid Services (CMS) is phasing out its Inpatient-Only (IPO) list, a move that will shift hundreds of medical procedures from inpatient to outpatient and ambulatory surgical
center (ASC) settings by January 1, 2029. This change, which began in 2026 with the removal of approximately 285 musculoskeletal procedures, will continue with over 600 more procedures proposed for removal in 2027, spanning digestive, respiratory, urinary, and endocrine service lines. The final group of about 800 complex procedures is scheduled to be removed in 2028. The removal from the IPO list means Medicare will pay for these procedures as outpatient services when deemed clinically appropriate by a physician, rather than automatically requiring an inpatient stay. This policy change fundamentally alters how site-of-care decisions are made, moving from automatic rules to clinical judgment influenced by patient acuity, physician preference, and payer policies.
Why It's Important?
This policy shift by CMS has profound implications for U.S. healthcare facilities, financial models, and patient care. Hospitals will experience a significant change in their operational landscape, as lower-acuity surgical cases migrate to outpatient departments and ASCs. This will result in inpatient units primarily handling more complex and acutely ill patients, impacting ICU ratios, staffing models, and room design. The financial reality is also substantial, as the reimbursement difference between inpatient Diagnosis-Related Group (DRG) payments and outpatient Ambulatory Payment Classification (APC) or ASC rates can amount to millions in annual revenue variance for health systems. Facilities that fail to adapt by investing in attractive outpatient options risk losing volume to independent ASCs or competitors. Furthermore, the need for flexible 'in-between' capacity, such as 23-hour stay units, will become critical to manage complications and bridge the gap between inpatient and outpatient care, ensuring continuity and quality of care.
What's Next?
Health systems must urgently stress-test their master plans and bed-need models, as pre-2026 volume assumptions may no longer be accurate, potentially overstating inpatient capacity needs and understating ambulatory demand. Organizations need to assess their surgical suite flexibility to accommodate both inpatient and outpatient procedures, and their recovery areas must be adaptable for varying lengths of stay. Financial strategies must be re-evaluated to account for the significant shift in reimbursement models. While Medicare Advantage and commercial authorization rules may lag CMS, facilities that document clinical outcomes for outpatient procedures now will gain a competitive advantage in negotiating favorable rates. The industry will likely see increased investment in ambulatory surgical capacity and the development of more 'in-between' care settings to manage the transition effectively. This period will demand strategic planning and operational agility from healthcare providers to navigate the evolving landscape of care delivery and reimbursement.
Beyond the Headlines
The phasing out of the IPO list represents a broader trend towards value-based care and cost containment in the U.S. healthcare system. It challenges the traditional hospital-centric model, pushing for more efficient and often less expensive outpatient care where clinically appropriate. This shift raises ethical considerations regarding patient safety and access, particularly for complex procedures that may require more robust post-operative support. Legal implications may arise from disputes over clinical appropriateness and payer coverage. Culturally, it requires a re-education of both providers and patients about where certain procedures can and should be performed. In the long term, this policy could accelerate the decentralization of healthcare services, fostering innovation in outpatient settings and potentially leading to a more competitive market for surgical procedures. However, it also places a greater burden on health systems to ensure seamless transitions of care and to manage the financial risks associated with reduced inpatient volumes.








